ClinicalTrials.gg
Status unknownNCT06390553Updated Apr 30, 2024

Effect of Virtual Reality on Freezing Phenomenon, Balance, Functional Mobility, Participation in Parkinson's Patients

An interventional study of Task-Oriented Virtual Reality Application with Crowd Simulation and Conventional Parkinson Rehabilitation in Parkinson's Disease and Freezing of Gait, sponsored by Ankara Yildirim Beyazıt University. Status unknown at 3 sites in Turkey (Türkiye). Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2024-04-30.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

This study was planned to investigate the use and results of virtual reality applications with specially prepared software for the rehabilitation of freezing phenomenon, which increases the falling anxiety of individuals with Parkinson's disease and causes social isolation. Individuals over the age of 50 who have been diagnosed with idiopathic Parkinson's disease by a specialist neurologist will be included in the study; Individuals evaluated in terms of balance, functional mobility, freezing phenomenon, participation, and cognitive status will be randomly divided into two groups receiving conventional treatment and additional virtual reality. After the preliminary evaluation, they will receive 8 weeks of treatment 4 days a week and will be evaluated after the treatment and 3 months after the treatment. In addition to the improvements that will emerge as a result of the treatments within the scope of the study, it is expected that the virtual reality application created with crowd simulation will provide more effective results in improving the parameters. Knowing the effects of exercises in crowds, which cannot be performed in the clinic, in the treatment of Parkinson's disease patients, whose freezing and freezing-related symptoms are aggravated, especially in crowded environments, will make significant contributions to the field.

02

Conditions studied

  • Parkinson's Disease
  • Freezing of Gait

Browse trials for

Keywords

  • virtual reality
  • rehabilitation
03

In context

Parkinson Disease

4,585 studies on the registry are indexed under Parkinson Disease; 1,097 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 3,365 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 238 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being diagnosed with Parkinson's disease by a qualified neurologist (diagnosed with idiopathic PD according to UK Brain Bank criteria
  • Being between 1-2.5 stages according to the Hoehn and Yahr Staging Scale
  • Volunteering to participate in the study
  • 50 years of age or older
  • Standardized Mini Mental Test score greater than 24
  • Patients experiencing an on-off period are in the "on" period
  • Not using deep brain stimulation or drug pump
  • Ability to walk independently on level ground (Functional Ambulation 3 and above according to classification)
  • Having a score of (≥2) on item 3 of the freezing while walking scale

Exclusion criteria

Exclusion Criteria:

  • Being any neurological or psychiatric disease other than Parkinson's disease
  • Cardiovascular, vestibular or musculoskeletal disease
  • Dyskinetic movements
  • Having vision problems that cannot be corrected with glasses or lenses
  • Hearing problems that cannot be corrected with a hearing aid
  • Using an assistive device
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Conventional group

    Patients in the conventional treatment group will be given 15 minutes of walking training in addition to the 45 minutes of conventional Parkinson's rehabilitation program. Patients in the conventional treatment group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors), stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Walking training to be given to the conventional group will include walking in different directions, walking with arm swing, walking over blocks, stopping and restarting walking, and changing direction activities.

    Procedure: Conventional Parkinson Rehabilitation

  • Experimental
    Virtual reality group

    Patients in the virtual reality group will be given a 45-minute conventional Parkinson's rehabilitation program similar to those in the conventional group, followed by 15 minutes of virtual reality walking training. Patients in the virtual reality group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), Respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors) stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Virtual reality applications increase the sense of reality in the individual with enriched virtual environments where sensory inputs are increased and provide the opportunity to perform activity training with a rich variety of tasks.

    Device: Task-Oriented Virtual Reality Application with Crowd Simulation · Procedure: Conventional Parkinson Rehabilitation

Interventions

  • DeviceTask-Oriented Virtual Reality Application with Crowd Simulation

    Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.

  • ProcedureConventional Parkinson Rehabilitation

    Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.

06

What researchers measure

Primary outcomes

  1. Freezing Phenomenon

    The presence and severity of freezing in patients will be evaluated with the Freezing of Gait Questionnaire. It consists of six items and each item is evaluated with a 5-point Likert scale. In the scale, which was adapted into Turkish by Candan et al., the score range is 0-24 and high scores indicate that the condition associated with frostbite is poor.

    Time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  2. Balance

    The balance of the patients will be evaluated with the Biodex Balance System. Postural stability and fall risk will be evaluated.

    Time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  3. Functional Mobility

    The Timed Get Up and Go Test (TUG) will be used to assess functional mobility. The TUG, which includes walking and turning functions, has been shown to be highly reliable and valid for individuals with Parkinson's disease). The person to be tested sits on a chair at normal height. With the command "Go", the person is asked to get up from the chair and walk 3 m forward at a normal walking speed and then return and sit back on the chair. It is usually administered twice and the average time is recorded. The person is allowed to use an assistive device (if available) and this is noted.

    Time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  4. Quality of Life Assessment

    Quality of life will be assessed with Parkinson's Disease Questionnaire (PDQ-8) developed specifically for individuals with Parkinson's disease. This validated questionnaire consists of eight questions to assess mobility, activities of daily living, emotional well-being, disease stigma, social support, cognition, communication and physical discomfort . In the questionnaire, the status of the person in the last month is questioned. The total score is between 0 and 100, with lower scores indicating better perceived health status due to the disease.

    Time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  5. Participation

    In order to evaluate social participation in the study, home participation (grocery shopping, meal preparation, daily household chores, money management, etc.), social participation (hobby, going out of the house, etc.), productivity (school, work, volunteer activities, etc.), electronic A scale consisting of 43 social networks (internet use, social communication, mobile phone use, etc.), 4 subunits and a total of 18 questions will be used.

    Time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

Secondary outcomes

  1. Executive functions

    The Trail Making Test (TMT) will be used to assess executive functions. The TMT measures executive functions such as working memory, complex attention, planning and set switching and requires visual-spatial processing and motor skills. TMT , A and B It consists of two parts. Part A of the TMT, which is an executive function test, evaluates the processing speed based on visual scanning ability, while part B evaluates the ability to change the setup between stimulus sets and to follow the sequentiality. Cangöz et al. determined the standardized values of the test for people over 50 years of age.

    Time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  2. The activity-specific balance confidence scale

    The activity-specific balance confidence scale will be used to assess the level of confidence the individual feels when performing balance-related activities of daily living. In the questionnaire consisting of 16 questions, the level of confidence felt ranges from 0% (completely insecure) to 100% (completely safe). The score obtained is divided by 16 to obtain a total score. 0-49 points indicate low functional level, 50-80 points indicate medium functional level and 81-100 points indicate high functional level. Scores below 67% indicate a fall risk in elderly individuals.

    Time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

07

Study locations

3 sites
  • Gazi University
    Ankara, Maltepe 06570, Turkey (Türkiye)
    • ÖNER BARUT, Asst. Prof. · Contact · onerbarut@gazi.edu.tr · +903125823277
    • ÖNER BARUT, Asst. Prof · Principal investigator
  • Kirsehir Ahi Evran University
    Kirşehi̇r, Merkez 40100, Turkey (Türkiye)
    • ÖZGE BARUT ÇELİK, MSc · Contact · ozgebarut@ahievran.edu.tr · +905527521401
    • Özge BARUT ÇELİK, MSc. · Principal investigator
    • Figen TUNCAY, Prof. · Sub investigator
  • Ankara Yildirim Beyazit University
    Ankara, Çubuk 06760, Turkey (Türkiye)
    • ERTUĞRUL ERTUĞRUL, Assoc. Prof. · Contact · edemirdel@aybu.edu.tr · +903129061928
    • ERTUĞRUL ERTUĞRUL, Assoc. Prof · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06390553
Responsible party
Ertuğrul Demirdel (Assoc. Prof., Ankara Yildirim Beyazıt University) — Principal investigator
First posted
Apr 30, 2024
Start date
Aug 2024 (estimated)
Primary completion
Feb 2026 (estimated)
Completion
Apr 2026 (estimated)
Last update
Apr 30, 2024

Study contacts

Ertuğrul DEMİRDEL, Assoc. Prof.
Contact
edemirdel@aybu.edu.tr
+903129061928
Özge BARUT ÇELİK, MSc.
Contact
ozgebarut@ahievran.edu.tr
+905527521401
Ertuğrul DEMİRDEL, Assoc. Prof.
study director · Ankara Yildirim Beyazıt University
Özge BARUT ÇELİK, MSc.
study chair · Kirsehir Ahi Evran Universitesi
Figen TUNCAY, Prof.
principal investigator · Kirsehir Ahi Evran Universitesi
Öner BARUT, Asst. Prof.
principal investigator · Gazi University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion